He, Dan <br/><br/>
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells.  [electronic resource] 

 -  PloS one  2013 
 - e54181 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0054181  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic<br/>HEK293 Cells<br/>HL-60 Cells<br/>Humans<br/>MCF-7 Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Naphthalenes--pharmacology<br/>Neoplasms--drug therapy<br/>Paclitaxel--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--pharmacology<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Xenograft Model Antitumor Assays<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors